We, therefore, conclude that the down-regulation of Il6 through Ccne1-depletion in HSCs is significantly involved in the reduced tumor burden of DEN/CCl4-treated Ccne1ΔHSC mice. The gene discussed is IL6; the disease is neoplasm.